ASTRAZENECA PHARMA Share price, NSE/BSE Forecast News and Quotes| Equitymaster

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  


Here is the latest stock price and chart of ASTRAZENECA PHARMA. For more details, see the ASTRAZENECA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Live BSE Quotes Aug 17, 2018 02:49:00 PM
Price (Rs)1,769.00 Open (Rs) 1,756.00 High (Rs) 1,777.35 Low (Rs) 1,745.80
% Change3.43 Volume 4,534 Value (Rs) 8,020,646 52-Week H/L 1,823.40 / 882.55
Live NSE Quotes Aug 17, 2018 2:49:54 PM
Price (Rs)1,765.00 Open (Rs) 1,736.50 High (Rs) 1,780.00 Low (Rs) 1,736.50
% Change3.32 Volume 47,722 Value (Rs) 84,022,217 52-Week H/L 1,822.00 / 880.20
EPS (Rs)* 10.42 P/E Ratio (x) 169.76 Market Cap (Rs m) 44,225.00 P/BV (x) 25.77
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Peer Group:
Quote & Graph
Advanced Charts new
Charts by TradingView


ASTRAZENECA PHARMA share price is up 3.4% to Rs 1,769.0 on the BSE. On the NSE, the ASTRAZENECA PHARMA share price is up 3.3% to Rs 1,765.0. The total volume of shares traded is 0.1 m.

Overall, the broader S&P BSE HEALTHCARE Index is trading up by 1.4%. And the benchmark S&P BSE SENSEX is at 37,992.2 (up 0.9%).

Over the last 30 days, the ASTRAZENECA PHARMA share price is up 26.0%. And over the last one year, ASTRAZENECA PHARMA share price is up 95.0%.

Today's Market

Sensex Extends Gains; Vedanta & Yes Bank Lead the Rally(12:30 pm)

Stock markets in India are trading higher taking cues from their Asian peers, which rebounded today following a strong lead in Wall Street.

Related Views On News

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY18); Net Profit Down 212.1% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ASTRAZENECA PHARMA has posted a net profit of Rs 32 m (down 212.1% YoY). Sales on the other hand came in at Rs 2 bn (up 35.1% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Banks are Raising FD Rates and That's Good News(Vivek Kaul's Diary)

Aug 7, 2018

Lending to the retail segment remains strong, whereas lending to the service sector has picked up dramatically.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks